{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:40:36Z","timestamp":1793047236370,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022831","name":"University of Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022831","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.schres.2026.05.015","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T13:57:48Z","timestamp":1779803868000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Can electroconvulsive therapy attenuate glial stress in schizophrenia? Longitudinal evidence from serum GFAP and S100B"],"prefix":"10.1016","volume":"295","author":[{"given":"Gozde","family":"Ataov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem Devrim","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Cirakli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit Haluk","family":"Yesilkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0891988713516542","article-title":"A review of longitudinal electroconvulsive therapy: neuroimaging investigations","volume":"27","author":"Abbott","year":"2014","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"9","key":"10.1016\/j.schres.2026.05.015_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106342","article-title":"Systematic review and meta-analysis of circulating S100B blood levels in schizophrenia","volume":"9","author":"Aleksovska","year":"2014","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/00207454.2020.1807979","article-title":"S100B protein: general characteristics and pathophysiological implications in the central nervous system","volume":"132","author":"Arrais","year":"2022","journal-title":"Int. J. Neurosci."},{"issue":"10","key":"10.1016\/j.schres.2026.05.015_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11101273","article-title":"The neurobiological basis of cognitive side effects of electroconvulsive therapy: a systematic review","volume":"11","author":"Bassa","year":"2021","journal-title":"Brain Sci."},{"issue":"7","key":"10.1016\/j.schres.2026.05.015_bb0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1586\/ern.09.59","article-title":"Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy","volume":"9","author":"Bernstein","year":"2009","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2014.03.035","article-title":"Glial cells as key players in schizophrenia pathology: recent insights and concepts of therapy","volume":"161","author":"Bernstein","year":"2015","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.schres.2026.05.015_bb0035","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2023.0728","article-title":"Understanding the mechanisms of action of electroconvulsive therapy: revisiting neuroinflammatory and neuroplasticity hypotheses","volume":"80","author":"Cano","year":"2023","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0040","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial cells in schizophrenia: a unified hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","article-title":"Glial cells in schizophrenia: a unified hypothesis","volume":"7","author":"Dietz","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2026.05.015_bb0050","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.bbamcr.2008.11.009","article-title":"S100B\u2019s double life: intracellular regulator and extracellular signal","volume":"1793","author":"Donato","year":"2009","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"4","key":"10.1016\/j.schres.2026.05.015_bb0055","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","article-title":"Time course for antipsychotic treatment response in first-episode schizophrenia","volume":"163","author":"Emsley","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.05.015_bb0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0165-5728(85)80063-1","article-title":"Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes","volume":"8","author":"Eng","year":"1985","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.schres.2013.07.024","article-title":"Increased expression of glial fibrillary acidic protein in prefrontal cortex in psychotic illness","volume":"150","author":"Feresten","year":"2013","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2026.05.015_bb0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jpsychires.2013.07.005","article-title":"S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: a postmortem study","volume":"47","author":"Gos","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1017\/neu.2018.32","article-title":"ECT in schizophrenia: a review of the evidence","volume":"31","author":"Grover","year":"2019","journal-title":"Acta Neuropsychiatr."},{"issue":"8","key":"10.1016\/j.schres.2026.05.015_bb0080","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1073\/pnas.081071198","article-title":"Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia","volume":"98","author":"Hakak","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0085","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-physiol-021909-135843","article-title":"Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior","volume":"72","author":"Halassa","year":"2010","journal-title":"Annu. Rev. Physiol."},{"issue":"7","key":"10.1016\/j.schres.2026.05.015_bb0090","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.pnpbp.2009.06.007","article-title":"Glial cell activation in response to electroconvulsive seizures","volume":"33","author":"Jansson","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia (Primer)","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"2","key":"10.1016\/j.schres.2026.05.015_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/npp.2009.164","article-title":"Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia","volume":"35","author":"Kinon","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.npp.1300565","article-title":"Electroconvulsive seizure treatment increases cell proliferation in rat frontal cortex","volume":"30","author":"Madsen","year":"2005","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(01)00115-9","article-title":"Structural brain abnormalities in patients with schizophrenia, epilepsy, and epilepsy with chronic interictal psychosis","volume":"108","author":"Marsh","year":"2001","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"2","key":"10.1016\/j.schres.2026.05.015_bb0115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/cells14020094","article-title":"The role of glial cells in the pathophysiology of epilepsy","volume":"14","author":"Onat","year":"2025","journal-title":"Cells"},{"issue":"10039","key":"10.1016\/j.schres.2026.05.015_bb0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.schres.2026.05.015_bb0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.psychres.2009.01.027","article-title":"Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: serum levels of neuron-specific enolase and S-100b protein","volume":"177","author":"Palmio","year":"2010","journal-title":"Psychiatry Res."},{"issue":"11","key":"10.1016\/j.schres.2026.05.015_bb0130","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1093\/brain\/awab223","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease","volume":"144","author":"Pereira","year":"2021","journal-title":"Brain"},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.05.015_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2013.02.005","article-title":"Indications for electroconvulsive treatment in schizophrenia: a systematic review","volume":"146","author":"Pompili","year":"2013","journal-title":"Schizophr. Res."},{"issue":"7","key":"10.1016\/j.schres.2026.05.015_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071604","article-title":"The diversity of intermediate filaments in astrocytes","volume":"9","author":"Potokar","year":"2020","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.schres.2026.05.015_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/mp.2016.235","article-title":"A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia","volume":"22","author":"Qin","year":"2017","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0150","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41398-022-02197-1","article-title":"Microglia sequelae: brain signature of innate immunity in schizophrenia","volume":"12","author":"Rodrigues-Neves","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2026.05.015_bb0155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.mp.4000889","article-title":"Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology","volume":"6","author":"Rothermundt","year":"2001","journal-title":"Mol. Psychiatry"},{"issue":"13","key":"10.1016\/j.schres.2026.05.015_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136237","article-title":"The inflammatory nexus: unraveling shared pathways and promising treatments in Alzheimer\u2019s disease and schizophrenia","volume":"26","author":"Russo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/YCT.0000000000000128","article-title":"Autobiographical memory and electroconvulsive therapy: final thoughts on the bathwater","volume":"30","author":"Sackeim","year":"2014","journal-title":"J. ECT"},{"issue":"1\u20132","key":"10.1016\/j.schres.2026.05.015_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.psychres.2008.01.002","article-title":"Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia\u2014original research and meta-analysis","volume":"167","author":"Schroeter","year":"2009","journal-title":"Psychiatry Res."},{"issue":"3","key":"10.1016\/j.schres.2026.05.015_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.9758\/cpn.2017.15.3.210","article-title":"How electroconvulsive therapy works?: understanding the neurobiological mechanisms","volume":"15","author":"Singh","year":"2017","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.schres.2026.05.015_bb0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.schres.2008.04.032","article-title":"Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia","volume":"103","author":"Steffek","year":"2008","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2026.05.015_bb0185","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/jnnp.2006.093427","article-title":"Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones","volume":"77","author":"Steiner","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2026.05.015_bb0190","doi-asserted-by":"crossref","first-page":"32","DOI":"10.64719\/pb.4070","article-title":"Factors associated with response to clozapine in schizophrenia: a review","volume":"44","author":"Suzuki","year":"2011","journal-title":"Psychopharmacol. Bull."},{"issue":"20","key":"10.1016\/j.schres.2026.05.015_bb0195","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1212\/WNL.0b013e3181fd62d2","article-title":"GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study","volume":"75","author":"Vos","year":"2010","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.schres.2026.05.015_bb0200","first-page":"327","article-title":"Hippocampal volume changes following electroconvulsive therapy: a systematic review and meta-analysis","volume":"2","author":"Wilkinson","year":"2017","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimaging"},{"issue":"2","key":"10.1016\/j.schres.2026.05.015_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/pcn.12024","article-title":"S100B and schizophrenia","volume":"67","author":"Yelmo-Cruz","year":"2013","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"12","key":"10.1016\/j.schres.2026.05.015_bb0210","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1007\/s12035-022-03054-4","article-title":"Can the imbalance between neurotrophic and apoptotic proteins Be the \u201cbeware the ides of march\u201d for unaffected relatives of schizophrenia patients?","volume":"59","author":"Yesilkaya","year":"2022","journal-title":"Mol. Neurobiol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:09:27Z","timestamp":1793045367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"alternative-id":["S0920996426001696"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.05.015","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can electroconvulsive therapy attenuate glial stress in schizophrenia? Longitudinal evidence from serum GFAP and S100B","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}